Publications To Date


    Filter Publications

    PAGE 59 OF 78 | DISPLAYING 871 - 885 OF 1166 RESULTS

    Drahos J. et al., MicroRNA profiles of Barrett's esophagus and esophageal adenocarcinoma: Differences in glandular non-native epithelium., [Epub ahead of print]., Cancer Epidemiology, Biomarkers and Prevention, Nov 24, 2015

    Wu Y. et al., High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer., [Epub ahead of print]., J. Mol. Diag., Nov 20, 2015

    Gasparini P. et al., microRNA classifiers are powerful diagnostic/ prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancer., [Epub ahead of print]., PNAS, Nov 16, 2015

    Maxfield K.E. et al., Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer., [Epub ahead of print]., Nat. Commun., Nov 16, 2015

    Jones K. et al., The impact of HLA class I and EBV latency-II antigen-specific CD8 T cells on the pathogenesis of EBV Hodgkin lymphoma., [Epub ahead of print]., Clin. & Exp. Immunol., Nov 13, 2015

    Pettapiece-Phillips R. et. al., Uninterrupted sedentary behavior downregulates BRCA1 gene expression., [Epub ahead of print]., Cancer Prevention Res., Nov 02, 2015

    Mackenzie R. et al., Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers., [Epub ahead of print]., Am. J. Surg. Pathol., Nov 01, 2015

    Pommier A.J.C. et al., Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer., [Epub ahead of print]., Cell Metabolism, Oct 26, 2015

    Rodriguez-Vida A. et al., Complexity of FGFR signalling in metastatic urothelial cancer., [Epub ahead of print]., J. Hematol. and Oncol., Oct 24, 2015

    Lee J.Y. et al., Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer., [Epub ahead of print]., Oncotarget, Oct 20, 2015

    Kim S.T. et. al., Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan., [Epub ahead of print]., Br. J. Cancer, Oct 20, 2015

    Sun B. et al., Selecting molecular therapeutic drug targets based on the expression profiles of intrahepatic cholangiocarcinomas and miRNA-mRNA regulatory networks., [Epub ahead of print]., Oncology Rep., Oct 15, 2015

    Felsenstein K.M. et al., Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression., [Epub ahead of print]., American Chemical Society, Oct 13, 2015

    Van Geldermalsen M. et al., ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer., [Epub ahead of print]., Oncogene, Oct 12, 2015

    Kim H.S. et al., Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma., [Epub ahead of print]., Oncotarget, Oct 09, 2015